INSIGHTS ON DRUG DEVELOPMENT

• Remote Measurements For Bulk Samples

  Remote Raman spectroscopy enables accurate material identification at long distances without complex focusing. Learn how pathlength, sample properties, and substrate choice impact signal quality.

• Getting The Most Out Of Cell-Based Assays With The Optimal Read Function

  Gain insight into a whole-well fluorescence analysis that improves sensitivity and reproducibility in cell-based assays by accounting for uneven cell distribution.

• Benchmarking Filtration Performance Of TFF Cassettes

  Optimize your protein purification workflow with tangential flow filtration by comparing membrane performance and exploring how protein concentration impacts flux and MWCO selection in lab-scale systems.

• History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era

  Peptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.

• Process Intensification: Your Guide To "Doing More With Less"

  8/5/2025

  Explore innovative strategies in process intensification to boost mAb production and hear from industry experts as they share solutions for scaling efficiency and navigating regulatory challenges.

• Efficient mAb Development With A Flexible Purification Toolkit

  6/4/2026

  Increasing mAb complexity is pushing purification beyond traditional platforms. See how flexible chromatography, optimized buffers, and adaptable workflows are becoming essential to achieve target purity.

• Navigating Nitrosamine Impurities In Pharmaceutical Drug Development

  3/3/2026

  Understanding formation mechanisms and potency categorization allows developers to mitigate risks early, ensuring regulatory compliance and patient safety without compromising product performance.

• Aggregate Analysis Of Tirzepatide

  12/11/2025

  A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.

• Right From The Start: Smarter Developability For Stronger Formulations

  2/4/2026

  Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.